Teyi Pharmaceutical Group Co Ltd Strategic Asset Allocation Index
Teyi Pharmaceutical Group Co Ltd strategic asset allocation index. Teyi Pharmaceutical Group Co Ltd (002728) has a Strategic Asset Allocation Index of 46.9% as of June 2023. Strategic assets (PP&E of CN¥660.23 Million plus long-term investments of CN¥-) total CN¥660.23 Million, measured against net assets of CN¥1.41 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 002728 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Teyi Pharmaceutical Group Co Ltd (2011–2021)
Strategic asset allocation index of Teyi Pharmaceutical Group Co Ltd from 2011 to 2021. This chart shows how Teyi Pharmaceutical Group Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2011 to 2021. As of June 2023, the index stands at 46.9%, representing strategic assets of CN¥660.23 Million against net assets of CN¥1.41 Billion CNY.
Teyi Pharmaceutical Group Co Ltd Strategic Asset Allocation Index by Year (2011–2021)
Teyi Pharmaceutical Group Co Ltd strategic asset allocation index by year from 2011 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Teyi Pharmaceutical Group Co Ltd from 2011 to 2021, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Teyi Pharmaceutical Group Co Ltd (002728) market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 47.7% | CN¥601.68 Million | CN¥601.68 Million | CN¥- | CN¥1.26 Billion | ▼ -3.6 pp |
| 2020 | 51.3% | CN¥554.23 Million | CN¥554.23 Million | CN¥- | CN¥1.08 Billion | ▲ +6.0 pp |
| 2019 | 45.3% | CN¥522.72 Million | CN¥522.72 Million | CN¥- | CN¥1.15 Billion | ▲ +2.0 pp |
| 2018 | 43.3% | CN¥481.01 Million | CN¥481.01 Million | CN¥- | CN¥1.11 Billion | ▼ -0.6 pp |
| 2017 | 43.9% | CN¥457.75 Million | CN¥457.75 Million | CN¥- | CN¥1.04 Billion | ▲ +4.4 pp |
| 2016 | 39.5% | CN¥349.92 Million | CN¥349.92 Million | CN¥- | CN¥886.57 Million | ▲ +3.2 pp |
| 2015 | 36.3% | CN¥291.61 Million | CN¥291.61 Million | CN¥- | CN¥804.30 Million | ▲ +20.8 pp |
| 2014 | 15.5% | CN¥113.84 Million | CN¥113.84 Million | CN¥- | CN¥735.64 Million | ▼ -17.8 pp |
| 2013 | 33.3% | CN¥116.67 Million | CN¥116.67 Million | CN¥- | CN¥350.14 Million | ▲ +16.4 pp |
| 2012 | 17.0% | CN¥48.37 Million | CN¥48.37 Million | CN¥- | CN¥285.34 Million | ▲ +0.3 pp |
| 2011 | 16.6% | CN¥37.49 Million | CN¥37.49 Million | CN¥- | CN¥225.51 Million | — |